Literature DB >> 25482181

Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction.

Robert E McCullumsmith1, Gerard Sanacora2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25482181      PMCID： PMC4262905          DOI： 10.1038/npp.2014.218

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

Review 1.  Glutamate transporters: confining runaway excitation by shaping synaptic transmission.

Authors:  Anastassios V Tzingounis; Jacques I Wadiche
Journal:  Nat Rev Neurosci       Date:  2007-12       Impact factor: 34.870

2.  Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse.

Authors:  Hao-wei Shen; Michael D Scofield; Heather Boger; Megan Hensley; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-04-16       Impact factor: 6.167

3.  Update on the neurobiology of schizophrenia: a role for extracellular microdomains.

Authors:  D Shan; S Yates; R C Roberts; R E McCullumsmith
Journal:  Minerva Psichiatr       Date:  2012-09-01

Review 4.  Astrocytes: Glutamate transport and alternate splicing of transporters.

Authors:  Aven Lee; David V Pow
Journal:  Int J Biochem Cell Biol       Date:  2010-09-29       Impact factor: 5.085

Review 5.  From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

Authors:  Gerard Sanacora; Mounira Banasr
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

6.  Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.

Authors:  Rose-Marie Karlsson; Kohichi Tanaka; Lisa M Saksida; Timothy J Bussey; Markus Heilig; Andrew Holmes
Journal:  Neuropsychopharmacology       Date:  2008-12-10       Impact factor: 7.853
  6 in total
  10 in total

Review 1.  Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems.

Authors:  Mojgan Oshaghi; Masoumeh Kourosh-Arami; Maryam Roozbehkia
Journal:  Neurol Sci       Date:  2022-09-28       Impact factor: 3.830

2.  Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions.

Authors:  Damiana Scuteri; Laura Rombolà; Michele Crudo; Chizuko Watanabe; Hirokazu Mizoguchi; Shinobu Sakurada; Kengo Hamamura; Tsukasa Sakurada; Luigi Antonio Morrone; Paolo Tonin; Giacinto Bagetta; Maria Tiziana Corasaniti
Journal:  Pharmaceutics       Date:  2022-05-07       Impact factor: 6.525

Review 3.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

4.  Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression.

Authors:  Marian T Sepulveda-Orengo; Kati L Healey; Ronald Kim; Alyson C Auriemma; Jennifer Rojas; Nicholas Woronoff; Rachel Hyppolite; Kathryn J Reissner
Journal:  Neuropsychopharmacology       Date:  2017-10-09       Impact factor: 7.853

5.  The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.

Authors:  P Steullet; J-H Cabungcal; S A Bukhari; M I Ardelt; H Pantazopoulos; F Hamati; T E Salt; M Cuenod; Kim Q Do; S Berretta
Journal:  Mol Psychiatry       Date:  2017-11-28       Impact factor: 15.992

6.  Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials.

Authors:  Chung-Ting Chang; Pei-Ju Hsieh; Hsin-Chien Lee; Chun-Hong Lo; Ka-Wai Tam; El-Wui Loh
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

7.  Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy.

Authors:  Damiana Scuteri; Laura Rombolà; Michele Crudo; Chizuko Watanabe; Hirokazu Mizoguchi; Shinobu Sakurada; Kengo Hamamura; Tsukasa Sakurada; Paolo Tonin; Maria Tiziana Corasaniti; Giacinto Bagetta
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

8.  A CDC42EP4/septin-based perisynaptic glial scaffold facilitates glutamate clearance.

Authors:  Natsumi Ageta-Ishihara; Maya Yamazaki; Kohtarou Konno; Hisako Nakayama; Manabu Abe; Kenji Hashimoto; Tomoki Nishioka; Kozo Kaibuchi; Satoko Hattori; Tsuyoshi Miyakawa; Kohichi Tanaka; Fathul Huda; Hirokazu Hirai; Kouichi Hashimoto; Masahiko Watanabe; Kenji Sakimura; Makoto Kinoshita
Journal:  Nat Commun       Date:  2015-12-10       Impact factor: 14.919

Review 9.  The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction.

Authors:  Le Xu; Jun Nan; Yan Lan
Journal:  Front Neural Circuits       Date:  2020-06-30       Impact factor: 3.492

10.  Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia.

Authors:  Ebrahim Haroon; Xiangchuan Chen; Zhihao Li; Thrusharth Patel; Bobbi J Woolwine; Xiaoping P Hu; Jennifer C Felger; Andrew H Miller
Journal:  Transl Psychiatry       Date:  2018-09-10       Impact factor: 6.222
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.